American Oncology Network Shares Clinical and Operational Expertise at NCODA International Spring Forum

FORT MYERS, Fla., April 22 2026 - American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, participated in the 2026 NCODA International Spring Forum, held April 15-17 in Denver. The meeting brought together oncology professionals from across the country to address timely clinical topics and practical challenges in cancer care.

Hosted by Network for Collaborative Oncology Development & Advancement (NCODA), the annual spring forum is designed to foster collaboration, share best practices and provide actionable strategies that can be implemented in community oncology settings to improve patient outcomes.

AON clinicians and pharmacy leaders contributed to several discussions focused on advancing patient-centered care, improving access to treatment and integrating innovation into everyday practice.

Brooke Peters, PharmD, BCOP, an AON clinical pharmacist, presented on emerging therapies for extensive-stage small cell lung cancer. Her session highlighted the clinical implications of the first DLL3-targeting bispecific T-cell engager therapy in the second-line setting.

Joan Martens, CPhT, RPhT, AON pharmacy operations supervisor, moderated a multidisciplinary panel examining upcoming Medicare changes and their impact on patient access and affordability. The discussion focused on the 2026 Medicare Part D redesign and the Medicare Prescription Payment Plan, with an emphasis on practical strategies to help patients navigate out-of-pocket costs and maintain access to care.

Sara Renzel, CPhT, COphT, an AON pharmacy prior authorization technician, led a session on the growing role of biomarker testing in oncology. She emphasized the importance of accurate documentation and interdisciplinary coordination to ensure timely treatment and payer approval.

Katie Goodman, RN, AON vice president of clinical research, participated in a panel exploring how artificial intelligence can help close gaps in clinical trial enrollment. The discussion highlighted how AI-enabled tools can support patient identification, streamline eligibility screening and improve access to clinical trials, particularly in community oncology settings.

Jesse Elder, CSPT, AON pharmacy operations services manager, presented a poster on drug monitoring in community oncology, highlighting strategies for smart monitoring and backup power systems to enhance safety and reduce costs

AON team members also contributed to poster presentations and panel discussions addressing operational efficiency, patient access and clinical innovation. Brooke Peters presented a poster on the first and only DLL3-Targeting Bispecific T-cell Engager (BiTE) Therapy for 2L ES-SCLC. Joan Martens also contributed to discussions on Medicare coverage changes and patient financial support strategies, while Sara Renzel presented on the role of biomarkers in shaping access to therapy. Katie Goodman further contributed to a panel discussion focused on leveraging artificial intelligence to improve clinical trial enrollment.

"AON is committed to advancing community oncology through collaboration, innovation, and a focus on the patient experience," said James Gilmore, PharmD, AON chief pharmacy and clinical services officer. "Forums like NCODA provide an important platform to share real-world insights and practical solutions that can be applied across practices to improve care delivery."

AON's participation reflects its ongoing commitment to supporting oncology professionals and ensuring patients receive exceptional, personalized care close to home.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON's rapidly expanding network represents more than 350 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most - providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
[email protected]